Measurement of intracerebral drug concentration using magnetic resonance spectroscopy (MRS)

Measurement of intracerebral drug concentration using magnetic resonance spectroscopy (MRS) - Brain drug concentration measurement with MRS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025586

Enrollment

Registered

2017-01-10

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heanlth vonlunteers

Interventions

Following oral administration of acetoaminophen 300 mg, brain NMR signals are observed using MRS. Following oral administration of diphenhydramine 50 mg, brain NMR signals are observed using MRS.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1

Exclusion criteria

Exclusion criteria: 1

Design outcomes

Primary

Measure	Time frame
peak information (Hz) of orally-administered drugs	—

Secondary

Measure	Time frame
subjective felleing of study participants	—

Countries

Japan

Contacts

Public ContactKazuko TAKEDA

Tohoku University Cyclotron and Radioisotope Center

clinic_supporter@cyric.tohoku.ac.jp022-795-4438

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026